Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breathing better, sleeping deeper? new trial tests rehab for COPD sleep troubles

NCT ID NCT06677268

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a respiratory rehabilitation program (exercise and education sessions over 8 weeks) can improve sleep quality in people with stable COPD. 90 adults aged 50 and older will be randomly assigned to either the rehab program or usual care. Sleep will be measured using overnight sleep studies (polysomnography) and questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
respiratory rehabilitation program (exercise sessions and educational workshops)
What this could lead to
If it works, this could show that respiratory rehabilitation improves sleep quality in people with stable COPD.
What could go wrong
This is a small, early-stage trial with only 90 participants. The results may not apply to all COPD patients, and sleep improvements might be modest or not occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female ≥ age 50 * COPD defined according to the GOLD 2022 criteria, clinically stable (without exacerbation for at least 4 weeks), with indication for respiratory rehabilitation * Absence of respiratory rehabilitation in the past 12 months * Patient affiliated to the social security system * For women of childbearing potential who have been on effective contraception (estrogen-progestogen or intrauterine device or tubal ligation) for 1 month. * For postmenopausal women: confirmatory diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit) * Patient who has read and understood the information letter and signed the consent form Exclusion Criteria: * BMI≥ 30 kg/m2 * Previously documented OSA (AHI \> 10/h) * Patient with a CPAP or NIV * Patient on systemic corticosteroid therapy * Patient on centrally acting therapy (benzodiazepine or opiate) * Patient with an occurrence of severe COPD exacerbation * Patient with other associated chronic respiratory insufficiency * Patient with active cancer * Patient with neuromuscular disease * Patient with an osteoarticular disability or traumatic or neurological sequelae preventing participation in the respiratory rehabilitation program * Psychiatric, cognitive or linguistic disorders with inability to understand to follow the protocol * Patient with a contraindication to respiratory rehabilitation or any pathology preventing physical rehabilitation * Patient with a cardiovascular contraindication to respiratory rehabilitation * Person deprived of liberty by an administrative or judicial decision or person placed under judicial safeguard, guardianship or curatorship * Person subject to a legal protection measure * Pregnant or parturient or breastfeeding woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (chronic obstructive pulmonary disease) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre de Sante Adir

    NOT_YET_RECRUITING

    Rouen, 76000, France

  • Chu Amiens

    NOT_YET_RECRUITING

    Amiens, 80054, France

  • Chu Rouen

    RECRUITING

    Rouen, 76031, France

  • Gh Le Havre

    NOT_YET_RECRUITING

    Le Havre, 76083, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.